https://www.selleckchem.com/products/akba.html
127, 95% CI 0.026-0.616; P=.01) revealed that GAS5 has a role in predicting recurrence after RFCA. Circulating lncRNA GAS5 is a potential biomarker for AF diagnosis and prognosis. Down-regulation of GAS5 occurs prior to left atrial enlargement and can be used for the prognosis of AF progression and recurrence. Circulating lncRNA GAS5 is a potential biomarker for AF diagnosis and prognosis. Down-regulation of GAS5 occurs prior to left atrial enlargement and can be used for the prognosis of AF progression and recurrence. Burnout affects abou
Like
Comment
Share
